Valuation Profarma Distribuidora de Produtos Farmacêuticos S.A.
Stocks
PFRM3
BRPFRMACNOR1
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.200 BRL | -8.82% |
|
-6.77% | -32.09% |
Company Valuation: Profarma Distribuidora de Produtos Farmacêuticos S.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 747.9 | 723.4 | 450 | 747.9 | 795.7 | 1,119 |
| Change | - | -3.28% | -37.8% | 66.21% | 6.39% | 40.68% |
| Enterprise Value (EV) 1 | 1,277 | 1,482 | 1,291 | 1,698 | 1,813 | 2,286 |
| Change | - | 16.05% | -12.88% | 31.53% | 6.77% | 26.1% |
| P/E | 14.3x | 9.25x | 5.56x | 10.6x | 6.95x | 9.42x |
| PBR | 0.71x | 0.67x | 0.38x | 0.6x | 0.61x | 0.83x |
| PEG | - | 0.2x | 1.62x | -0.8x | 0.1x | 2.46x |
| Capitalization / Revenue | 0.14x | 0.11x | 0.06x | 0.09x | 0.08x | 0.1x |
| EV / Revenue | 0.23x | 0.23x | 0.17x | 0.2x | 0.18x | 0.2x |
| EV / EBITDA | 8.52x | 9.11x | 4.54x | 5.74x | 5.3x | 5.65x |
| EV / EBIT | 9.95x | 10.9x | 5.09x | 6.5x | 6.05x | 6.53x |
| EV / FCF | -50.4x | -136x | -22.6x | -101x | 11.3x | 34.7x |
| FCF Yield | -1.98% | -0.73% | -4.42% | -0.99% | 8.82% | 2.88% |
| Dividend per Share 2 | - | 0.2706 | 0.1733 | 0.3858 | 0.575 | - |
| Rate of return | - | 4.59% | 4.72% | 6.32% | 8.86% | - |
| EPS 2 | 0.4268 | 0.6377 | 0.6596 | 0.574 | 0.934 | 0.9697 |
| Distribution rate | - | 42.4% | 26.3% | 67.2% | 61.6% | - |
| Net sales 1 | 5,481 | 6,413 | 7,816 | 8,662 | 10,154 | 11,451 |
| EBITDA 1 | 149.9 | 162.7 | 284.2 | 295.6 | 342.1 | 404.5 |
| EBIT 1 | 128.3 | 136.3 | 253.8 | 261.1 | 299.7 | 350.1 |
| Net income 1 | 52.33 | 78.19 | 80.87 | 70.4 | 114.6 | 118.9 |
| Net Debt 1 | 528.9 | 758.4 | 840.9 | 950 | 1,017 | 1,167 |
| Reference price 2 | 6.100 | 5.900 | 3.670 | 6.100 | 6.490 | 9.130 |
| Nbr of stocks (in thousands) | 122,611 | 122,611 | 122,611 | 122,611 | 122,611 | 122,611 |
| Announcement Date | 3/16/21 A | 3/16/22 A | 3/15/23 A | 3/7/24 A | 3/18/25 A | 3/17/26 A |
1BRL in Million2BRL
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 150M | |
| 21.03x | 0.25x | 14.51x | 0.37% | 104B | |
| 29.88x | 0.23x | 14.99x | 0.89% | 54.46B | |
| 45.45x | 3.21x | 29.79x | 1.36% | 23.27B | |
| 11.51x | 0.2x | 4.84x | 2.63% | 8.17B | |
| 13.08x | 0.99x | 8.01x | 2.59% | 7.49B | |
| 6.07x | 0.1x | 2.7x | 4.88% | 6.87B | |
| 9.22x | 1.73x | 5.53x | 3.56% | 6.19B | |
| 25.64x | 1.21x | 15.16x | 2.91% | 5.36B | |
| 14.2x | - | - | 2.29% | 3.71B | |
| Average | 19.57x | 0.99x | 11.94x | 2.39% | 21.98B | |
| Weighted average by Cap. | 24.39x | 0.65x | 15.07x | 1.09% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PFRM3 Stock
- Valuation Profarma Distribuidora de Produtos Farmacêuticos S.A.
Select your edition
All financial news and data tailored to specific country editions
